Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Medtronic said today that it paid $200 million in cash to acquire Sapiens Steering Brain Stimulation and its deep-brain stimulation technology, even as it gears up to pay $43 billion for Covidien.
Eindhoven, Holland-based Sapiens is developing a DBS device with a lead featuring 40 stimulation points that’s designed for more precise stimulation of targeted areas of the brain, according to a press release. Read more
In a breakthrough surgery a team of physicians at Peking University implanted a 3D-printed vertebra for the 1st time in a 12-year-old boy with a malignant tumor on his spinal cord.
The doctors replaced a piece of the patient’s spine with 3D-printed material, shaping the implant with pores that will allow bones to grow in and hold it in place. Because 3D-printing allows for new, more complex-shaped implants, doctors didn’t need any screws or cement to hold the artificial vertebra in place, Forbes reported. Read more
Medtronic could wind up taking a 40% share of the patient monitoring market after the close of its $43 billion COV acquisition, Medtronic CEO Omar Ishrak told employees last week.
That’s because Covidien already enjoys a 15% share, which Medtronic could augment via acquisition, Ishrak explained during a “town hall” meeting August 22. Read more